Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change
Trinity Biotech announced a 1-for-30 reverse split of its American Depositary Shares (ADSs), effective at the open of trading on July 24, 2026, to regain compliance with Nasdaq's $1.00 minimum bid price requirement. The ratio change modifies the ADS representation from 1 ADS representing 20 Class A ordinary shares to 1 ADS representing 600 Class A ordinary shares, with The Bank of New York Mellon acting as the depositary.
Key figures
- New ads ratio
- 1:600
- Old ads ratio
- 1:20
- Effective date
- July 24, 2026
- Reverse split ratio
- 1-for-30
- Nasdaq min bid price
- $1.00
- Investment threshold price
- $5.00
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.